NHLBI TOPMed - NHGRI CCDG: The Vanderbilt AF Ablation Registry
Anthropometry (2)
- height - Subject's height (phv00265926.v4.p3)
- weight - Subject's weight (phv00265927.v4.p3)
Demographics (4)
- age - Age at enrollment (phv00265921.v4.p3)
- age_diagnosis - Age at AF diagnosis (phv00265922.v4.p3)
- sex - Gender of participant (phv00265923.v4.p3)
- SEX - Sex of subject (phv00571546.v1.p3)
Disease Events (6)
- diabetes - Diabetes at enrollment (phv00265929.v4.p3)
- EF_ever_50 - EF ever <50% (phv00265935.v4.p3)
- heart_failure - Heart failure at enrollment (phv00265930.v4.p3)
- hypertension - Hypertension at enrollment (phv00265928.v4.p3)
- myocardial_infarction - Myocardial infarction at enrollment (phv00265931.v4.p3)
- valvular_heart_disease - Valvular heart disease at enrollment (phv00265932.v4.p3)
Race and Ethnicity (2)
- ethnicity - Ethnicity of participant (phv00265925.v4.p3)
- race - Race of participant (phv00265924.v4.p3)
Study Administration (1)
- CONSENT - Consent deternmined by DAC (phv00253604.v4.p3)
Other (16)
- af_status - AF status (phv00265920.v4.p3)
- ANALYTE_TYPE - Analyte Type (phv00253611.v4.p3)
- BODY_SITE - Body site where sample was collected (phv00253610.v5.p3)
- Funding_Source - Project funding source (phv00310119.v4.p3)
- IS_TUMOR - Tumor status (phv00253612.v4.p3)
- LA_size_echo - LA size by echo (closest to enrollment) (phv00265933.v4.p3)
- LVEF_echo - LVEF by echo (closest to enrollment) (phv00265934.v4.p3)
- SAMPLE_ID - Sample ID (phv00253609.v4.p3)
- SAMPLE_ID - Sample ID (phv00253607.v4.p3)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00310118.v4.p3)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00310122.v3.p3)
- SUBJECT_ID - De-identified Subject ID (phv00265919.v4.p3)
- SUBJECT_ID - Subject ID (phv00253603.v4.p3)
- SUBJECT_ID - Subject ID of Phenotype Data (phv00253606.v4.p3)
- TOPMed_Phase - TOPMed Phase (phv00310120.v4.p3)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00310121.v3.p3)